Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects

Journal of Nuclear Medicine

Volumn 44, Issue 6, 2003, Pages 961-966

  Robeson, William ^a   Dhawan, Vijay ^a   Belakhlef, Abdel ^a   Ma, Yilong ^a   Von Pillai, ^a   Chaly, Thomas ^a   Margouleff, Claude ^a   Bjelke, David ^a   Eidelberg, David ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Dopamine transporter; Dosimetry; N (3 fluoropropyl) 2 carbomethoxy 3 (4 iodophenyl)nortropane; PET

Indexed keywords

DOPAMINE TRANSPORTER; N (3 FLUOROPROPYL) 2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL)NORTROPANE; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; CARRIER PROTEIN; DIAGNOSTIC AGENT; MEMBRANE PROTEIN; NERVE PROTEIN; NORTROPANE DERIVATIVE; TROPANE DERIVATIVE;

ABDOMEN; ARTICLE; BLADDER; BRAIN SCINTISCANNING; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOSIMETRY; HUMAN; IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; THORAX; ADULT; AGED; ANTIBODY SPECIFICITY; BLOOD; BODY BURDEN; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; LIVER; LUNG; MALE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MIDDLE AGED; RADIOMETRY; URINE; WHOLE BODY COUNTING;

ADULT; AGED; BODY BURDEN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; LIVER; LUNG; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METABOLIC CLEARANCE RATE; MIDDLE AGED; NERVE TISSUE PROTEINS; NORTROPANES; ORGAN SPECIFICITY; RADIOMETRY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TROPANES; URINARY BLADDER; WHOLE-BODY COUNTING;

EID: 0037487020     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Abi-Dargham A, Gandelman MS, DeErausquin GA, et al. SPECT imaging of dopamine transporters in human brain with iodine-123 fluoroalkyl analogs of β-CIT. J Nucl Med. 1996;37:1129-1133.
2. 18F] N-3-fluoropropyl-2-β-carbomethoxy-3-β-(4-iodophenyl) nortropane and the first human study with positron emission tomography. Nucl Med Biol 1996;23:999-1004.
3. Seibyl JP, Marek K, Sheff K, et al. Iodine-123-β-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J Nucl Med. 1998;39:1500-1508.
4. Kazumata K, Dhawan V, Chaly T, et al. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med 1998;39:1521-1530.
5. 123I]FPCIT SPECT. J Nucl Med 1999;40 753-761.
6. Habraken JB, Booij J, Slomka P, et al. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm. J Nucl Med. 1999;40:1091-1097
7. 123I-FP-CIT SPECT striatal uptake. Mov Disord. 2000;15 692-698.
8. 18F]FPCIT binding in early stage Parkinson's disease: a PET study. Synapse. 2002;45:125-133
9. Abi-Dargham A, Innis RB, Wisniewski G, et al. Human biodistribution and dosimetry of iodine-123-fluoroalkyl analogs of β-CIT. Eur J Nucl Med. 1997,24:1422-1425.
10. Jones SC, Alavi A, Christman D, et al The radiation dosimetry of 2-[F-18]fluoro-2-deoxy-D-glucose in man. J Nucl Med. 1982;23:613-617.
11. Dhawan V, Belakhlef A, Robeson W, et al. Bladder wall radiation dose in humans from fluorine-18-FDOPA. J Nucl Med. 1996;37:1850-1852.
12. Stabin MG. MIRDOSE. personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 1996;37:538-546.
13. International Commission on Radiological Protection. Reference Man: Anatomical, Physiological and Metabolic Characteristics. ICRP Publication 23. New York, NY: Pergamon Press, 1975.
14. Sorenson JA, Phelps ME Physics in Nuclear Medicine. 2nd ed Philadelphia, PA: WB Saunders; 1987:200-206.
15. International Commission on Radiological Protection. Limits for the Intake of Radionuclides by Workers. ICRP Publication 30: Part 1. New York, NY: Pergamon Press; 1979.
16. Ishikawa T, Dhawan V, Kazumata K, et al Comparative nigrostriatal dopaminergic imaging with iodine-123-βCIT-FP/SPECT and fluorine-18-FDOPA/ PET. J Nucl Med 1996;37:1760-1765.
17. 18F-DOPA uptake: absence of aging effect. J Cereb Blood Flow Metab. 1993;13:881-888.
18. 18F-FPCIT uptake in Parkinson's disease [abstract]. J Nucl Med 2002;43(suppl):56P.
19. Radiation Dose Estimates for Radiopharmaceuticals [on-line database]. Oak Ridge, TN: Radiation Internal Dose Information Center, Oak Ridge Institute for Science and Education, 1996. www.orau.gov/ehsd/ridic.htm. Accessed January 7, 1997